Search Results - "Hack SP"

Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply.

Authors: Chow PKH Hack SP Spahn JH et al.

Source: Lancet (London, England) [Lancet] 2024 Aug 17; Vol. 404 (10453), pp. 657-658.

Publication Type: Letter; Comment

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma.

Authors: Yopp A Chen M Cheng AL et al.

Source: Journal of hepatology [J Hepatol] 2026 Jun; Vol. 84 (6), pp. 1102-1111. Date of Electronic Publication: 2026 Jan 22.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.

Authors: Wang, Qian Xu, Chunwei Wang, Wenxian et al.

Source: Thoracic Cancer. Sep2023, Vol. 14 Issue 26, p2715-2731. 17p.

Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan.

Authors: Morimoto, Kosuke Moriwaki, Kensuke Nishikawa, Yoshitaka et al.

Source: PharmacoEconomics - Open. May2026, Vol. 10 Issue 3, p471-489. 19p.

Study protocol for a single-arm phase Ib/II trial of Ivonescimab combined with adapted guided stereotactic body radiotherapy and chemotherapy in patients with locally advanced pancreatic cancer.

Authors: Tang, Ziniu Shi, Fang Zhu, Kunli et al.

Source: BMC Cancer. 10/14/2025, Vol. 25 Issue 1, p1-10. 10p.

Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.

Authors: Hatanaka, Takeshi Kakizaki, Satoru Hiraoka, Atsushi et al.

Source: Cancer Medicine. Mar2023, Vol. 12 Issue 5, p5293-5303. 11p.

GABAergic neurons in the ventrolateral periaqueductal gray mediate fentanyl withdrawal and self-administration in mice.

Authors: Chen Y Cheng X Cao Y et al.

Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2026 Jun 05. Date of Electronic Publication: 2026 Jun 05.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE

The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.

Authors: Wu, Hui Shu, Wenzhi Ding, Yongfeng et al.

Source: BMC Cancer. 8/25/2025, Vol. 25 Issue 1, p1-14. 14p.

Efficacy and safety of anti-PD-1 antibodies plus small molecule anti-angiogenic drugs and chemotherapy in gastric cancer peritoneal metastasis: a multicenter real-world study.

Authors: Guo, Fen Wang, Deqiang Zhang, Luyao et al.

Source: BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-12. 12p.

原发性肝癌分子靶向药物相关蛋白尿中西医结合诊疗专家共识.

Alternate Title: Expert consensus on the integrated traditional Chinese and Western medicine diagnosis and treatment of proteinuria associated with molecular targeted drugs for primary liver cancer.

Authors: 李秀惠 (AUTHOR) lixiuhui@sohu.com

Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. May2026, Vol. 42 Issue 5, p1015-1026. 12p.

Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice.

Authors: Wang, Xinmeng Geng, Qian Jiang, Hua et al.

Source: BMC Immunology. 4/8/2025, Vol. 26 Issue 1, p1-10. 10p.

Identification of a novel subtype of SPP1 + macrophages expressing SIRPα: implications for tumor immune evasion and treatment response prediction.

Authors: Chen, Kun Li, Yida Ni, Jianjiao et al.

Source: Experimental Hematology & Oncology. 12/18/2024, Vol. 13 Issue 1, p1-17. 17p.

Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.

Authors: de Moraes, Francisco Cezar Aquino Pasqualotto, Eric Chavez, Matheus Pedrotti et al.

Source: BMC Cancer. 2/21/2024, Vol. 24 Issue 1, p1-11. 11p.

Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma.

Authors: Osuga, Takahiro Tanaka, Shingo Kubo, Tomohiro et al.

Source: Case Reports in Oncology. 2024, Vol. 17 Issue 1, p407-416. 10p.

A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab.

Authors: Saito, Naoto Hatanaka, Takeshi Nakano, Sachi et al.

Source: Clinical Case Reports. Jul2022, Vol. 10 Issue 7, p1-8. 8p.

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)

Authors: Lorenzen, Sylvie Schwarz, Alix Pauligk, Claudia et al.

Source: BMC Cancer. 6/19/2023, Vol. 23 Issue 1, p1-8. 8p.

Adjuvant recombinant human endostatin combined with toripalimab (anti-PD-1) in locally advanced melanoma: an exploratory phase 2 clinical trial incorporating single-cell RNA/TCR/BCR sequencing.

Authors: Hu X Xu Y Wang Z et al.

Source: Molecular cancer [Mol Cancer] 2026 Apr 27; Vol. 25 (1). Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Advanced Mucosal Melanoma Therapies: Current Status and Future Directions.

Authors: Zhang Y Zhao D Wu D

Source: Current treatment options in oncology [Curr Treat Options Oncol] 2026 Apr 07; Vol. 27 (1). Date of Electronic Publication: 2026 Apr 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study.

Authors: Fang, Wei Peng, Xingqiao Zhou, Qun

Source: Journal of Cardiothoracic Surgery. 8/2/2024, Vol. 19 Issue 1, p1-8. 8p.

Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial.

Authors: Hao, Yun Xie, Fei Zhou, Yongjie et al.

Source: Trials. 7/19/2024, Vol. 25 Issue 1, p1-9. 9p.